Stock Events

Stock Events

Inspyr Therapeutics 

$0
2
-$0-18.18% Monday 21:58

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
1.39M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

22NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.04
0.03
0.09
0.16
Expected EPS
0
Actual EPS
0

Financials

-Profit Margin
Profitable
2016
2017
2018
2019
2020
2021
0Revenue
2.7MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NSPX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Pharmaceuticals: Other
Health Technology
Manufacturing
Pharmaceutical Preparation Manufacturing
Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.
Show more...
CEO
Country
US
ISIN
US75619J1034

Listings

OTC Link
US
RBSH

0 Comments

Share your thoughts

FAQ

What is Inspyr Therapeutics stock price today?▼
The current price of NSPX is $0 USD — it has decreased by -18.18% in the past 24 hours. Watch Inspyr Therapeutics stock price performance more closely on the chart.
What is Inspyr Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Inspyr Therapeutics stocks are traded under the ticker NSPX.
What is Inspyr Therapeutics market cap?▼
Today Inspyr Therapeutics has the market capitalization of 1.39M
What were Inspyr Therapeutics earnings last quarter?▼
NSPX earnings for the last quarter are 0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Inspyr Therapeutics revenue for the last year?▼
Inspyr Therapeutics revenue for the last year amounts to 0 USD.
What is Inspyr Therapeutics net income for the last year?▼
NSPX net income for the last year is 2.7M USD.
In which sector is Inspyr Therapeutics located?▼
Inspyr Therapeutics operates in the Manufacturing sector.
When did Inspyr Therapeutics complete a stock split?▼
The last stock split for Inspyr Therapeutics was on October 01, 2019 with a ratio of 1:25.
Where is Inspyr Therapeutics headquartered?▼
Inspyr Therapeutics is headquartered in Westlake Village, US.